Navigation Links
National Stroke Association Teams With Clinical Trial Matching Service CureLauncher

Bloomfrield Hills, MI (PRWEB) July 23, 2013

Michigan-based CureLauncher (, developer of a patent-pending and proprietary clinical trial matching service, today announced an exclusive partnership with the National Stroke Association—a leading educational, prevention and advocacy group for individuals and their families and health care professionals confronting health issues related to strokes.

National Stroke Association members and visitors will be directed to, where specially trained relationship managers help individuals find a clinical trial that may offer access to a new diagnostic test, treatment or rehabilitative approach.

“We are thrilled to partner with CureLauncher,” said Jim Baranski, National Stroke Association CEO. “Together, we can make progress in preventing, treating and understanding this challenging condition that impacts so many American families. In particular, clinical medical research is bringing us new diagnostic techniques to identify individuals at risk for stroke, as well as life strategies and other approaches to prevention.”

The power of clinical trials. Nearly 200 million Americans have a chronic disease such as diabetes, heart disease, asthma or cancer. Less than five percent of them know where to find new treatments available in clinical trials according to the Center for Information & Study on Clinical Research Participation (CISCRP). Yet, some of America’s best medical care is available through these clinical trials.

"CureLauncher redefines the approach to clinical trials by putting people and their families first," said David Fuehrer, CureLauncher President, who is also a two-time cancer survivor and active speaker and volunteer for various support communities.

“We are excited to collaborate with the National Stroke Association. We want to help them in their quest to prevent or alleviate what is now the nation’s fourth leading cause of death,” Fuehrer added.

About National Stroke Association:
The National Stroke Association was formed in 1984 to fill a void as the only national nonprofit healthcare organization focusing 100 percent of its resources and attention on stroke. In its brief history, National Stroke Association has become a leading national resource on stroke and the driving force behind efforts to improve stroke prevention, treatment, rehabilitation and support for all impacted by stroke. Learn more at:

About CureLauncher:
CureLauncher gives people the power and support to make a life-changing decision. Its patent-pending matching system helps people find treatment options that are aligned with their unique goals and conditions. Take Control. Know Your Options™. Learn more at

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related biology technology :

1. UV Flu Technologies Expands Its International Footprint
2. Elsevier Supports International Crisis Aid Through Pillars of Hope Campaign
3. International Attendance for Networking and Education at Informex Beyond Manufacturing
4. Sundberg Kicks Off National Expansion With Openings of New Headquarters, Logistically Centric Mega Warehouses
5. Leading Investigator to Present Clinical Data on Generex Oral-lyn™ at International Diabetes Federation Meetings in Dubai
6. Experts Launch the Alliance for Fertility Preservation at the International Society for Fertility Preservations 2nd World Congress
7. First Free-Standing International Mesothelioma Research Laboratory Opens in Los Angeles
8. Cord Blood America Announces Exclusive Agreement With National Childrens Leukemia Foundation to Store Stem Cells
9. PAREXEL International to Present at J.P. Morgan Healthcare Conference
10. DFH Pharma to Collaborate With National Cancer Institute to Develop Second-Generation HIV Maturation Inhibitor Drugs
11. Elsevier Launches Bilingual International Nursing Skill Training and Management Platform:
Post Your Comments:
(Date:6/23/2016)... WA (PRWEB) , ... June 23, 2016 , ... ... announces the release of its second eBook, “Clinical Trials Patient Recruitment and Retention ... recruitment and retention in this eBook by providing practical tips, tools, and strategies ...
(Date:6/23/2016)... June 23, 2016   Boston Biomedical , ... compounds designed to target cancer stemness pathways, announced ... granted Orphan Drug Designation from the U.S. Food ... gastric cancer, including gastroesophageal junction (GEJ) cancer. Napabucasin ... to inhibit cancer stemness pathways by targeting STAT3, ...
(Date:6/23/2016)... A person commits a crime, and the detective ... the criminal down. An outbreak of foodborne illness ... (FDA) uses DNA evidence to track down the bacteria that ... It,s not. The FDA has increasingly used a complex, cutting-edge ... illnesses. Put as simply as possible, whole genome sequencing is ...
(Date:6/23/2016)... (PRWEB) , ... June 23, 2016 , ... ... Plate® YM (Yeast and Mold) microbial test has received AOAC Research Institute approval ... of microbial tests introduced last year,” stated Bob Salter, Vice President of Regulatory ...
Breaking Biology Technology:
(Date:6/15/2016)... New York , June 15, 2016 /PRNewswire/ ... a new market report titled "Gesture Recognition Market by ... and Forecast, 2016 - 2024". According to the report, ... USD 11.60 billion in 2015 and is estimated ... reach USD 48.56 billion by 2024.  ...
(Date:6/7/2016)... 7, 2016  Syngrafii Inc. and San Antonio ... that includes integrating Syngrafii,s patented LongPen™ eSignature "Wet" ... collaboration will result in greater convenience for SACU ... while maintaining existing document workflow and compliance requirements. ... Highlights: ...
(Date:6/2/2016)... --  The Weather Company , an IBM Business (NYSE: ... in which consumers will be able to interact with IBM ... voice or text and receive relevant information about the product ... have long sought an advertising solution that can create a ... and valuable; and can scale across millions of interactions and ...
Breaking Biology News(10 mins):